Skip to main content

Design, Synthesis, and Biological Evaluation of Nedd4 E3 Ubiquitin Ligase Small Molecule Inhibitors

  • Conference paper
  • First Online:
Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012)

Part of the book series: Lecture Notes in Electrical Engineering ((LNEE,volume 251))

  • 1838 Accesses

Abstract

Protein ubiquitination and deubiquitination are closely associated with tumorigenesis. The incidence of most tumorigenesis associated with abnormal expression of oncogenes and tumor suppressor genes. Nedd4 is an E3 ubiquitin ligase and highly expressed in prostate cancer cells, breast cancer cells, and ovarian cancer cells [1]. Based on the three-dimensional structure of Nedd4 ubiquitin ligase and its characteristics, we used computer simulations and structural biology information to design and synthesize compounds to inhibit the activity of Nedd4 ubiquitin ligase. In this paper, we would like to report the design, synthesis, and biological activities of these compounds. Among those compounds, five new compounds have not been reported before. All the newly synthesized compounds were characterized by 1H NMR and were tested for their antitumor activities using DU145, PC3, and PNT1A cell lines. The results showed that 4-(4-chlorobenzoyl) piperazin-1-yl) (4-(phenoxymethyl) phenyl) methanone has antiproliferative activity against DU145 with an IC50 of 3.86 μM.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Novaro V, Radisky D (2002) 93rd annual meeting of the american association for cancer research, San Francisco, CA, USA, 6–10 April 2002. Breast Cancer Res 4:165–168

    Article  Google Scholar 

  2. Xu LL, Shi Y, Petrovics G et al (2003) PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. Cancer Res 63:4299–4304

    Google Scholar 

  3. Weissman A, Lowenstein L, Porat M et al (2005) The effect of hormone replacement therapy cessation on heart rate variability in postmenopausal women. Clin Auton Res 15:411–413

    Google Scholar 

  4. Sudol M (1996) The WW module competes with SH3 domain. Trends Biochem Sci 21:161–163

    CAS  Google Scholar 

  5. Macias MJ, Hyvönen M, Baraldi E et al (1996) Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide. Nature 382:646–649

    Article  CAS  Google Scholar 

  6. Chen HI, Sudol M (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci USA 92:7819–7823

    Article  CAS  Google Scholar 

  7. Murillas R, Simms KS, Hatakeyama S et al (2002) Identification of developmentally expressed proteins that functionally interact with Nedd4 ubiquitin ligase. J Biol Chem 277:2897–2907

    Article  CAS  Google Scholar 

  8. Wang J (2006) SUMO conjugation and cardiovasclular development. Front Biosci 14:1219–1229

    Google Scholar 

  9. Mulwad VV, Langi BP, Chaskar AC (2011) Synthesis of novel biologically active heterocyclic compounds from 2-oxo-2H-benzopyran-6-yl-imidazolidine. Acta Pol Pharm 68:39–47

    CAS  Google Scholar 

  10. Reddy KK, Ravinder T, Prasad RB et al (2011) Evaluation of the antioxidant activity of capsiate analogues in polar, nonpolar, and micellar media. J Agric Food Chem 59:564–569

    Article  CAS  Google Scholar 

  11. Ruchelman AL, Man HW, Chen R et al (2011) 1,1-Diarylalkenes as anticancer agents: dual inhibitors of tubulin polymerization and phosphodiesterase 4. Bioorg Med Chem 19:56–74

    Article  Google Scholar 

  12. Wesson DR (2011) Psychedelic drugs, hippie counterculture, speed and phenobarbital treatment of sedative-hypnotic dependence: a journey to the Haight Ashbury in the Sixties. J Psychoactive Drugs 43:153–164

    Article  Google Scholar 

  13. Tamami B, Ghasemi S (2008) Palladium nanoparticles supported on layered hydroxide salts and their use in carbon–carbon coupling organic reactions. J Iranian Chem Soc 5:S26–S32

    Article  CAS  Google Scholar 

  14. Müller C, Schöniger-Hekele M, Schernthaner R et al (2008) Percutaneous ethanol instillation therapy for hepatocellular carcinoma - a randomized controlled trial. Wien Klin Wochenschr 120:608–618

    Article  Google Scholar 

  15. Biju P, Taveras A, Yu Y et al (2008) 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. Bioorg Med Chem Lett 18:228–231

    Article  CAS  Google Scholar 

  16. Oxford JS (2000) Zanamivir (Glaxo Wellcome). IDrugs 3:447–459

    CAS  Google Scholar 

  17. Kamal A, Reddy MK, Ramaiah MJ et al (2011) Synthesis of aryl-substituted naphthalene-linked pyrrolobenzodiazepine conjugates as potential anticancer agents with apoptosis-inducing ability. ChemMedChem 6:1665–1679

    Google Scholar 

  18. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

    Article  CAS  Google Scholar 

  19. Xu J, Wu F, Mei M (2005) MTT assay tumor chemo sensitivity. China Medicine 01:12--13

    Google Scholar 

  20. Miladi S, Abid N, Debarnôt C (2012) In vitro antiviral activities of extracts derived from Daucus maritimus seeds. Nat Prod Res 26:1027–1032

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This research is supported by the Tianjin Natural Science Foundation grant (10JCZDJC16800).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Aipo Diao .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fu, X. et al. (2014). Design, Synthesis, and Biological Evaluation of Nedd4 E3 Ubiquitin Ligase Small Molecule Inhibitors. In: Zhang, TC., Ouyang, P., Kaplan, S., Skarnes, B. (eds) Proceedings of the 2012 International Conference on Applied Biotechnology (ICAB 2012). Lecture Notes in Electrical Engineering, vol 251. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37925-3_195

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37925-3_195

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37924-6

  • Online ISBN: 978-3-642-37925-3

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics